Biennial CEM in Women With a Personal History of Breast Cancer
NCT06105749
This study is recruiting at 6 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Breast Cancer
- Breast Neoplasms
- Breast Cancer Female
- Neoplasms
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 30 to 79 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Wendie Berg
- Last updated on ClinicalTrials.gov
- August 19, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Pennsylvania · 6
- UPMC Magee-Womens Imaging - Bethel Park · Bethel Park, PA
- UPMC Magee at the Lemieux Sports Complex · Cranberry Township, PA
- Magee Womancare Monroeville · Monroeville, PA
- Hillman Cancer Center at Shadyside · Pittsburgh, PA
- Magee-Womens Hospital · Pittsburgh, PA
- UPMC West Mifflin Outpatient Center · West Mifflin, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.